Sign In
Buy NMTC
$1.69
-0.0100 (-0.588%)
At Close: Jul 31, 2026
Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet
12:57pm, Friday, 04'th Apr 2025
U.S. stocks traded lower midway through trading, with the Dow Jones index dipping more than 1,100 points on Friday. Beijing unveiled a retaliatory 34% tariff on U.S. goods—mirroring the rate announc
NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock
08:30am, Friday, 04'th Apr 2025
EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care op
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
04:05pm, Thursday, 03'rd Apr 2025
EDEN PRAIRIE, Minn., April 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care op
NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update
01:12pm, Tuesday, 18'th Mar 2025
EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgic
NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace
09:00am, Tuesday, 18'th Mar 2025
EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgic
NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy
08:46am, Tuesday, 18'th Mar 2025
NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Today's Marketplace (TMP) is proud to announce a featured interview with NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) CEO Dave Rosa and Jessi
NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
09:00am, Tuesday, 11'th Mar 2025
Submission for New Intended Use That Leverages Company's Patented OneRF® Technology Platform Expected in May 2025 EDEN PRAIRIE, Minn., March 11, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologi
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
09:00am, Wednesday, 05'th Mar 2025
EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgic
NeuroOne Medical Technologies Corporation (NMTC) Q1 2025 Earnings Call Transcript
10:18am, Wednesday, 12'th Feb 2025
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q1 2025 Earnings Conference Call February 12, 2025 8:30 AM ET Company Participants Dave Rosa - CEO Ron McClurg - CFO Chris Volker - COO Operato
NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update
08:00am, Wednesday, 12'th Feb 2025
Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenue from Zimmer Biomet EDEN PRAIRIE, Minn., Feb. 12, 2025 (GLOB
NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time
11:00am, Wednesday, 05'th Feb 2025
EDEN PRAIRIE, Minn., Feb. 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica
NeuroOne® Regains Compliance with Nasdaq Listing Requirements
10:56am, Tuesday, 04'th Feb 2025
EDEN PRAIRIE, Minn., Feb. 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica
NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million
08:30am, Friday, 10'th Jan 2025
First Quarter Fiscal 2025 Revenue Includes a One-Time Upfront Payment of $3.0 Million in Collaboration Revenue from Zimmer Biomet and $3.2M in Product Revenue
Stock Picks From Seeking Alpha's December 2024 New Analysts
08:00am, Tuesday, 07'th Jan 2025
In December, we welcomed 29 new analysts to Seeking Alpha and in this article we are showcasing their stock picks and investment strategies. Five buy picks are highlighted on Viasat, Newmont, NeuroOne
NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST
08:30am, Friday, 03'rd Jan 2025
Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Na
